|

BL-M14D1 and Atezolizumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Atezolizumab, BL-M14D1

Pipeline

Phase 3: 1

Top Sponsors

  • SystImmune Inc.1

Indications

  • Small Cell Carcinoma1
  • Lung Cancer Stage IV1
  • Small Cell Lung Cancer Extensive Stage1
  • SCLC1
  • Lung Cancer Metastatic1

Springdale, Arkansas1 trial

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Highlands Oncology Group

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.